Skip to main content

Advertisement

Log in

Effects of moderate-intensity continuous training and high-intensity interval training on serum levels of Resistin, Chemerin and liver enzymes in Streptozotocin-Nicotinamide induced Type-2 diabetic rats

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

The aim of this study was to investigate the effects of of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) in serum resistin, chemerin, insulin, liver enzymes and lipid profiles levels.

Methods

24 Wistar rats with mean weight of 200 ± 50 g were randomly assigned to non-diabetic rats (ND-Cnt), diabetic control (D-Cnt), diabetic training groups. The diabetic training group received 10 weeks of HIIT (D-HIIT) and MICT (D-MICT) following the induction of diabetes. Evaluating resistin, chemerin and insulin hormones levels through ELISA. FBS and liver enzyme levels were measured by biochemical kits.

Results

HIIT and MICT resulted in a significant decrease in resistin, chemerin and fasting blood glucose (P < 0.05) compared to the D-Cnt (P < 0.05). Serum values of FBS, lipid profiles and liver enzyme (P < 0.05) decreased significantly more in the HIIT group compared with the MICT group (P < 0.05). As well as, the resistin level positively and significantly associated with values of ALT and chemerin level positively and significantly associated with values of ALT, ALP and AST in all rat (P < 0.05).

Conclusion

In general, our findings demonstrated that the HIIT leads to better improvements in serum liver enzyme levels, FBS and lipid profiles compared to MICT. HIIT therefore appears to be an important time-efficient treatment for treatment with type 2 diabetes rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets used to analyze during this study are available from thecorresponding author on reasonable request.

Abbreviations

ALT:

Alanine aminotransferase

GGT:

Gamma –glutamyltransferase

AST:

Aspartate trans aminase

ALP:

Alkaline phosphatase

HIIT:

High-intensity interval training

MICT:

Moderate-intensity continuous training

ND-Cnt:

Non diabetic rats

D-Cnt:

Diabetic control rats

D-MICT:

Diabetic rats that received moderate-intensity continuous training

D-HIIT:

Diabetic rats that were treated with high-intensity interval training

TAG:

triglyceride

HDL-C:

High-density lipoprotein cholesterol

LDL-C:

Low-density lipoprotein cholesterol

References

  1. Shi G-J, Shi G-R, Zhou J-Y, Zhang W-J, Gao C-Y, Jiang Y-P, et al. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomed Pharmacother. 2018;101:510–27.

    CAS  PubMed  Google Scholar 

  2. Shi G-J, Zheng J, Wu J, Qiao H-Q, Chang Q, Niu Y, et al. Beneficial effects of Lycium barbarum polysaccharide on spermatogenesis by improving antioxidant activity and inhibiting apoptosis in streptozotocin-induced diabetic male mice. Food Funct. 2017;8(3):1215–26.

    CAS  PubMed  Google Scholar 

  3. Dehdashtian E, Mehrzadi S, Yousefi B, Hosseinzadeh A, Reiter RJ, Safa M, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33.

    CAS  PubMed  Google Scholar 

  4. Shi G-J, Li Y, Cao Q-H, Wu H-X, Tang X-Y, Gao X-H, et al. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: a systematic review of the literature. Biomed Pharmacother. 2019;109:1085–99.

    CAS  PubMed  Google Scholar 

  5. König M, Bulik S, Holzhütter H-G. Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol. 2012;8(6):e1002577.

    PubMed  PubMed Central  Google Scholar 

  6. Ahangarpour A, Shabani R, Farbood Y. The effect of betulinic acid on leptin, adiponectin, hepatic enzyme levels and lipid profiles in streptozotocin–nicotinamide-induced diabetic mice. Research in pharmaceutical sciences. 2018;13(2):142–8.

    PubMed  PubMed Central  Google Scholar 

  7. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, et al. Relationship between metabolic syndrome, alanine aminotransferase levels, and liver disease severity in a multiethnic north American cohort with chronic hepatitis B. Diabetes Care. 2018:dc180040.

  8. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol. 2006;169(6):2042–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, et al. Regulation of fasted blood glucose by resistin. Science. 2004;303(5661):1195–8.

    CAS  PubMed  Google Scholar 

  10. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–12.

    CAS  PubMed  Google Scholar 

  11. Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, et al. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology. 2012;56(6):2142–53.

    CAS  PubMed  Google Scholar 

  12. Ahmed OM, Mahmoud AM, Abdel-Moneim A, Ashour MB. Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats. Diabetol Croat. 2012;41:2.

    Google Scholar 

  13. Boutari C, Perakakis N, Mantzoros CS. Association of Adipokines with development and progression of nonalcoholic fatty liver disease. Endocrinol Metab. 2018;33(1):33–43.

    CAS  Google Scholar 

  14. Asalah AK, Alsayed MA, Al-Aleem DIA, El Malkey NF. Serum resistin, vaspin and chemerin in rats with non alcoholic fatty liver disease: correlation with metabolic and haemostatic parameters. Basic Sciences of Medicine. 2014;3(4):69–84.

    Google Scholar 

  15. S-g R, Song S-H, Choi K-C, Katoh K, Wittamer V, Parmentier M, et al. Chemerin—a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun. 2007;362(4):1013–8.

    Google Scholar 

  16. Hong C, Yan-jiao W, Yi J, Cheng Z, YA-qun G. Relationship between chemerin and metabolic syndrome. Journal of Xi'an Jiaotong University (Medical Sciences). 2011;6:013.

    Google Scholar 

  17. Zabel BA, Silverio AM, Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol. 2005;174(1):244–51.

    CAS  PubMed  Google Scholar 

  18. Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, et al. Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp Mol Pathol. 2013;95(2):199–205.

    CAS  PubMed  Google Scholar 

  19. Döcke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, et al. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol. 2013;169(5):547–57.

    PubMed  Google Scholar 

  20. Roessner C, Paasch U, Kratzsch J, Glander HJ, Grunewald S. Sperm apoptosis signalling in diabetic men. Reprod BioMed Online. 2012;25(3):292–9.

    PubMed  Google Scholar 

  21. Hansen D, Dendale P, Jonkers RA, Beelen M, Manders RJ, Corluy L, et al. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients. Diabetologia. 2009;52(9):1789–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, et al. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59(1):56–66.

    CAS  PubMed  Google Scholar 

  23. Afzalpour ME, Chadorneshin HT, Foadoddini M, Eivari HA. Comparing interval and continuous exercise training regimens on neurotrophic factors in rat brain. Physiol Behav. 2015;147:78–83.

    CAS  PubMed  Google Scholar 

  24. Ephraim RK, Acheampong E, Swaray SM, Odame Anto E, Agbodzakey H, Adoba P, et al. Developing a modified low-density lipoprotein (M-LDL-C) Friedewald’s equation as a substitute for direct LDL-C measure in a Ghanaian population: a comparative study. Journal of Lipids. 2018;2018:1–9.

    Google Scholar 

  25. Husna F, Suyatna FD, Arozal W, Poerwaningsih EH. Antihyperglycemia effect and antioxidant capacity of Murraya koenigii in nicotinamide-Streptozotocin induced diabetic rats. Acta Biomedica Indonesiana. 2018.

  26. Ranasinghe C, Hills A, Constantine G, Finlayson G, Katulanda P, King N. Study protocol: a randomised controlled trial of supervised resistance training versus aerobic training in Sri Lankan adults with type 2 diabetes mellitus: SL-DART study. BMC Public Health. 2018;18(1):176.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Gonzalez JT, Fuchs CJ, Betts JA, Van Loon LJ. Liver glycogen metabolism during and after prolonged endurance-type exercise. American Journal of Physiology-Endocrinology and Metabolism. 2016;311(3):E543–E53.

    PubMed  Google Scholar 

  28. George N, Kumar TP, Antony S, Jayanarayanan S, Paulose C. Effect of vitamin D 3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br J Nutr. 2012;108(8):1410–8.

    CAS  PubMed  Google Scholar 

  29. Schmatz R, Perreira LB, Stefanello N, Mazzanti C, Spanevello R, Gutierres J, et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie. 2012;94(2):374–83.

    CAS  PubMed  Google Scholar 

  30. Oh S, Tanaka K, Warabi E, Shoda J. Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. Med Sci Sports Exerc. 2013;45(12):2214–22.

    CAS  PubMed  Google Scholar 

  31. Chiş I, Mureşan A, Oros A, Nagy A, Clichici S. Protective effects of quercetin and chronic moderate exercise (training) against oxidative stress in the liver tissue of streptozotocin-induced diabetic rats. Acta Physiol Hung. 2016;103(1):49–64.

    Google Scholar 

  32. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6(3):456–80.

    PubMed  PubMed Central  Google Scholar 

  33. Poolsil P, Promprom W, Talubmook C. Anti-hyperglycemic and anti-hyperlipidemic effects of extract from Houttuynia cordata thumb. In streptozotocin-induced diabetic rats. Pharmacognosy Journal. 2017;9(3):382–7.

    CAS  Google Scholar 

  34. Liu G, Wang X-H. Research advances in the effects of excise and diet on LPL and its mechanism. Sheng li ke xue jin zhan [Progress in physiology]. 2014;45(2):87–92.

    Google Scholar 

  35. Ferland DJ, Watts SW. Chemerin: a comprehensive review elucidating the need for cardiovascular research. Pharmacol Res. 2015;99:351–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Kralisch S, Weise S, Sommer G, Lipfert J, Lossner U, Bluher M, et al. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept. 2009;154(1–3):102–6.

    CAS  PubMed  Google Scholar 

  37. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 2008;582(5):573–8.

    CAS  PubMed  Google Scholar 

  38. Yang M, Yang G, Dong J, Liu Y, Zong H, Liu H, et al. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2010;58(7):883–6.

    CAS  Google Scholar 

  39. Buechler C. Chemerin in liver diseases. Endocrinology & Metabolic Syndrome. 2014;3:4.

    Google Scholar 

  40. Lin X, Yang H, Wang X. Effects of aerobic exercise and dieting on chemerin and its receptor CMKLR1 in the livers of type 2 diabetic rats. Zhongguo ying yong sheng li xue za zhi= Zhongguo yingyong shenglixue zazhi= Chinese journal of applied physiology. 2017;33(5):426–30.

    PubMed  Google Scholar 

  41. Shen C, Zhao C-Y, Wang W, Wang Y-D, Sun H, Cao W, et al. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterol. 2014;14(1):39.

    PubMed  PubMed Central  Google Scholar 

  42. Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic rats. Chem Biol Interact. 2010;186(2):200–10.

    CAS  PubMed  Google Scholar 

  43. Salemi Z, Tond SB, Fallah S, Shojaii A, Seifi M. The effect of Morus alba leaves extract and powder on resistin levels and liver transaminase enzymes activities in diabetes. Cell Mol Biol. 2016;62(6):112–8.

    CAS  PubMed  Google Scholar 

  44. Hosseini M, Afsariehee B, Reza M. The effect of high intensity interval training and aloe Vera consumption on resistin and insulin resistance index in diabetic rat. Feyz Journal of Kashan University of Medical Sciences. 2018;22(4):370–8.

    Google Scholar 

Download references

Funding

Funding for this study was provided by Arak University. The funding sources had no other role other than financial support.

Author information

Authors and Affiliations

Authors

Contributions

MP, EKH, AS, and ART were responsible for the study concept and design. MP, EKH, AS, and ART contributed to data acquisition. ELAMM, LFB, EKT, CAP and EAVM assisted with data analysis and interpretation of findings. MP, EKH, AS, and ART drafted the manuscript. All authors provided critical revision of the manuscript for important intellectual content and approved final version for publication.

Corresponding author

Correspondence to Parastesh Mohammad.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving animals were in accordance with the ethical standards of the Ethical Committee of Experimental Animals of the Faculty of Medicine in Inonu Univer-sity, at which the studies were conducted.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohammad, P., Esfandiar, K.Z., Abbas, S. et al. Effects of moderate-intensity continuous training and high-intensity interval training on serum levels of Resistin, Chemerin and liver enzymes in Streptozotocin-Nicotinamide induced Type-2 diabetic rats. J Diabetes Metab Disord 18, 379–387 (2019). https://doi.org/10.1007/s40200-019-00422-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-019-00422-1

Keywords

Navigation